Dow Today: Johnson & Johnson (JNJ) Lower
The
Dow Jones Industrial Average
(
^DJI
) is trading down 136 points (-1.1%) at 12,754 as of Friday, Feb 10, 2012, 1:39 p.m. ET. During this time, 413.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 818.6 million. The NYSE advances/declines ratio sits at 632 issues advancing vs. 2,323 declining with 103 unchanged.
Holding back the Dow today is
(NYSE:
), which is lagging the broader Dow index with a 40-cent decline (-0.6%) bringing the stock to $64.49. This single loss is lowering the Dow Jones Industrial Average by 3.03 points or roughly accounting for 2.2% of the Dow's overall loss. Volume for Johnson & Johnson currently sits at 6.8 million shares traded vs. an average daily trading volume of 10.7 million shares.
Johnson & Johnson has a market cap of $177.51 billion and is part of the
sector and
industry. Shares are down 1.1% year to date as of Thursday's close. The stock's dividend yield sits at 3.5%.
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 13, below the average drugs industry P/E ratio of 15.9 and below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Johnson & Johnson as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Johnson & Johnson Ratings Report.
null
